These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 25636078
1. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model. Sadrpour SA, Serhal M, Khrestian CM, Lee S, Fields T, Dittrich HC, Waldo AL. J Cardiovasc Pharmacol; 2015 May; 65(5):494-9. PubMed ID: 25636078 [Abstract] [Full Text] [Related]
2. Ranolazine terminates atrial flutter and fibrillation in a canine model. Bhimani AA, Yasuda T, Sadrpour SA, Khrestian CM, Lee S, Zeng D, Belardinelli L, Waldo AL. Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042 [Abstract] [Full Text] [Related]
3. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. Goldstein RN, Khrestian C, Carlsson L, Waldo AL. J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294 [Abstract] [Full Text] [Related]
4. Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results. Cakulev I, Lacerda AE, Khrestian CM, Ryu K, Brown AM, Waldo AL. J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1266-73. PubMed ID: 21615815 [Abstract] [Full Text] [Related]
6. Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter. Ortiz J, Nozaki A, Shimizu A, Khrestian C, Rudy Y, Waldo AL. Circulation; 1994 Jun; 89(6):2860-9. PubMed ID: 8205702 [Abstract] [Full Text] [Related]
7. Vanoxerine, a new drug for terminating atrial fibrillation and flutter. Matsumoto N, Khrestian CM, Ryu K, Lacerda AE, Brown AM, Waldo AL. J Cardiovasc Electrophysiol; 2010 Mar; 21(3):311-9. PubMed ID: 19817929 [Abstract] [Full Text] [Related]
12. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. Kumagai K, Nakashima H, Gondo N, Saku K. J Cardiovasc Electrophysiol; 2003 Aug; 14(8):880-4. PubMed ID: 12890053 [Abstract] [Full Text] [Related]
13. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. Buchanan LV, LeMay RJ, Walters RR, Hsu CY, Brunden MN, Gibson JK. J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021 [Abstract] [Full Text] [Related]
14. Characterization of the excitable gap in a functionally determined reentrant circuit. Studies in the sterile pericarditis model of atrial flutter. Niwano S, Ortiz J, Abe H, Gonzalez X, Rudy Y, Waldo AL. Circulation; 1994 Oct; 90(4):1997-2014. PubMed ID: 7522990 [Abstract] [Full Text] [Related]
18. Circus movement atrial flutter in the canine sterile pericarditis model. Cryothermal termination from the epicardial site of the slow zone of the reentrant circuit. Isber N, Restivo M, Gough WB, Yang H, el-Sherif N. Circulation; 1993 May; 87(5):1649-60. PubMed ID: 8491021 [Abstract] [Full Text] [Related]
19. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway. Schoels W, Yang H, Gough WB, el-Sherif N. Circ Res; 1991 Apr; 68(4):1117-26. PubMed ID: 2009611 [Abstract] [Full Text] [Related]
20. Characterization of double potentials in a functionally determined reentrant circuit. Multiplexing studies during interruption of atrial flutter in the canine pericarditis model. Shimizu A, Nozaki A, Rudy Y, Waldo AL. J Am Coll Cardiol; 1993 Dec; 22(7):2022-32. PubMed ID: 8245362 [Abstract] [Full Text] [Related] Page: [Next] [New Search]